Portfolio company
GNA Biosolutions GmbH
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
GNA Biosolutions GmbH manufactures ultrafast molecular diagnostic instruments and assays for healthcare providers to detect pathogens near patients or at the point of care.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Inbiome
Inbiome develops molecular diagnostic platforms for rapid bacterial identification to support healthcare providers, pharmaceutical companies and military medical units in treating infections.
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
